Casdin Capital, LLC - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 90 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.

Quarter-by-quarter ownership
Casdin Capital, LLC ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q2 2020$12,286,000
-7.0%
1,850,373
-18.5%
0.73%
-48.1%
Q1 2020$13,211,000
-31.8%
2,270,000
+5.1%
1.40%
-21.3%
Q4 2019$19,375,000
-99.9%
2,160,000
+22.0%
1.78%
+12.6%
Q3 2019$15,283,950,000
-22.5%
1,770,0000.0%1.58%
-14.3%
Q2 2019$19,717,800,000
+132198.7%
1,770,000
+58.0%
1.85%
+12.8%
Q1 2019$14,904,000
+33.9%
1,120,586
+55.5%
1.64%
-14.1%
Q4 2018$11,133,000
+8.5%
720,5860.0%1.90%
+52.8%
Q3 2018$10,261,000720,5861.25%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Versant Venture Management, LLC 3,561,150$6,125,1783.26%
Redmile Group, LLC 8,509,126$14,635,6970.70%
Avidity Partners Management LP 2,733,800$4,702,1360.19%
Frazier Life Sciences Management, L.P. 1,430,878$2,461,1100.16%
Artia Global Partners LP 95,170$163,6920.07%
Worth Venture Partners, LLC 43,772$75,2880.04%
SkyOak Wealth, LLC 60,875$104,7050.03%
Point72 Asset Management, L.P. 5,924,867$10,190,7710.03%
CORNERCAP INVESTMENT COUNSEL INC 76,811$132,1150.02%
Houlihan Financial Resource Group, Ltd. 20,000$380.02%
View complete list of GRITSTONE ONCOLOGY INC shareholders